Rajiv Agarwal

University of Indianapolis — United States

Medicine · Health Sciences

67h-index18.0kcitations580works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood Pressure and Hypertension Studies(119), Dialysis and Renal Disease Management(74), Hormonal Regulation and Hypertension(54), Diabetes Treatment and Management(40), Chronic Kidney Disease and Diabetes(36)

Publications580 total

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease–Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis‐Stimulating Agent Dose
Hemodialysis International·2025Open Access
Choice of oncologist and influencing factors: analysis of the Pancreatic Cancer Action Network registry
The Oncologist·2025Open Access
Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes
Journal of the American College of Cardiology·2025
Abstract 4369231: Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes
Circulation·2025
Abstract 4369336: Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk: Insights from the FIDELITY Program
Circulation·2025
Abstract 4369294: Estimated Lifetime Benefits of Finerenone on Cardiorenal Morbidity and Mortality in Patients with Type 2 Diabetes and Chronic Kidney Disease
Circulation·2025
Abstract 4366042: The HFpEF-ABA Algorithm and Finerenone in Chronic Kidney Disease with Type 2 Diabetes: A FINE-HEART Analysis
Circulation·2025
End‐Of‐Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition
Cancer Medicine·2025Open Access
Win-Odds Analysis of Deaths and Hospitalization in Patients Taking Vadadustat or Darbepoetin Alfa for CKD-Related Anemia Undergoing Dialysis
Journal of the American Society of Nephrology·2025
Serum Potassium, Hyperkalemia, and the Effect of Hyperkalemia on Treatment Efficacy with Empagliflozin, Finerenone, or Both: A CONFIDENCE Trial Report
Journal of the American Society of Nephrology·2025
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease
Journal of the American College of Cardiology·2025· 4 citedOpen Access
Inter‐organ crosstalk: The kidney's role in systemic health and disease
Journal of Internal Medicine·2025· 5 citedOpen Access
Atypical presentation of L3 vertebral body osteochondroma mimicking cauda equina syndrome: a case report
Annals of Medicine and Surgery·2025Open Access
Design and Implementation of a Primary Palliative Care Education Program for Hematology-Oncology Advanced Practice Providers: Insights From a Three-Year Cohort
Journal of Pain and Symptom Management·2025Open Access
Teaching Communication Skills and Developing Comfort With Difficult Conversations: A Combined Palliative Care-Oncology Simulation Session for Hematology/Oncology Fellows
JCO Oncology Practice·2025
Role of Artificial Intelligence in Green Banking Services in India
JOURNAL GLOBAL VALUES·2025
Spinal teratoma in an adolescent: a rare case report with intradural presentation and review of management strategies
Annals of Medicine and Surgery·2025Open Access
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction
JACC Heart Failure·2025· 3 citedOpen Access
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Future Oncology·2025· 2 citedOpen Access
<b>Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of</b><b>Heart Failure and Chronic Kidney Disease</b>
2025Open Access
page 1 of 29Next →

Frequent Co-authors

George L. Bakris(12), Peter Rossing(7), Meg Jardine(7), Adeera Levin(7), David C. Wheeler(7), Vlado Perkovic(7), Hiddo J.L. Heerspink(6), Dick de Zeeuw(6), Luís M. Ruilope(5), Peter Kolkhof(5), Amer Joseph(5), Stefan D. Anker(4), Bertram Pitt(4), Giuseppe Remuzzi(4), Vivekanand Jha(4), Kenneth W. Mahaffey(4), Carol A. Pollock(4), Christoph Wanner(4), Christina Nowack(3), Katherine R. Tuttle(3)